EPCAM and rectal cancer: Epithelial cell adhesion molecule (EpCAM; CD326) is a cell surface receptor which is abundantly overexpressed in the rectal cancer tissue as compared with adjacent normal tissues [24], so it can be considered as an ideal CRC biomarker in active targeting.